Cubist’s Cubicin gets boost from expanded indication
The FDA has approved broader use for Cubist Pharmaceuticals’ Cubicin intravenous antibiotic to also treat bloodstream infections, including a form ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.